Biogen Idec (BIIB) Slashed 25% Following Failed Sale
Tweet Send to a Friend
Shares of Biogen Idec Inc. (Nasdaq: BIIB) are down 25% following the news ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
